Intellia Therapeutics, Inc. ($NTLA)
Filing Information
| Accession Number | 0001193125-26-006275 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 7, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
6,379
Total Value
$58,750.59
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Financial Officer | Common Stock | โ | Jan 5, 2026 | Sale | 6,379 | $9.21 | $58,750.59 | 99,683 | Direct | โ | View Details |